期刊文献+

鼻咽癌组织中CerbB-2的表达及其意义

CerbB-2 Expression and Significance in Patients with Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的:探讨表皮生长因子受体-2(cerbB-2)在鼻咽癌组织中的表达情况及其意义。方法:采用免疫组织化学SP法检测cerbB-2在90例鼻咽癌组织和22例鼻咽炎性组织中的表达情况,分析cerbB-2表达水平与鼻咽癌临床病理因素的关系。结果:90例鼻咽癌组织中cerbB-2表达的阳性率为65.56%,22例鼻咽炎性组织中cerbB-2表达的阳性率为31.82%(P<0.05);鼻咽癌组CerbB-2表达在淋巴结分期N_2和N_3患者中阳性率为81.0%,N_0和N_1患者阳性率为52.1%(P<0.05),而与患者年龄、性别、临床分期、T分期和远处转移无明显相关(P>0.05)。结论:CerbB-2在鼻咽癌组织中高表达,它可能是鼻咽癌发生和发展过程中的一个重要因素。 Objective: To investigate the biological significance of CerbB-2 expression in nasopharyngeal carcinoma. Methods: The expression of CerbB-2 was detected in 90 nasopharyngeal carcinoma tissues and 22 nasopharyngitis tissues by SP immunohistochemical method. The relationship between CerbB-2 expression and clinicopathological characteristics of nasopharyngeal carcinoma was investigated. Results: The positive expression rate of CerbB-2 protein was 65.56% in nasopharyngeal carcinoma tissues, and 31.82% in nasopharyngitis tissues, with a significant difference (P〈0.05). The ratio of expression was 81.0% in patients of N2 and N3 lymth node stage, significantly different from that in patients of N0 and N1 lymph node stage (52.1%, P〈0.05). The expression of CerbB-2 gene was not correlated with age, gender, clinical stage, T stage and distant metastasis of nasopharyngeal carcinoma (P〉0.05). Conclusion: There is a high expression of CerbB-2 in nasopharyngeal carcinoma tissues, which might be an important event in the pathogenesis and progression of nasopharyngeal carcinoma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第23期1350-1352,共3页 Chinese Journal of Clinical Oncology
基金 广西壮族自治区自然科学基金资助(编号:桂科自0640196)~~
关键词 鼻咽癌 CERBB-2 免疫组织化学 Nasopharyngeal carcinoma CerbB-2 Immunohistochemistry
  • 相关文献

参考文献9

  • 1Okita J, Hatta C, Terada T, et al. Concurrent chemo-radiotherapy for nasopharyngeal carcinoma[J]. Auris Nasus Larynx, 2004, 31(1): 43-47.
  • 2朱正鹏,贾国凤,马健波,沈勤,杨微荣,王进.子宫内膜腺癌C-erbB-2COX-2过度表达的相关性分析[J].中国肿瘤临床,2008,35(11):633-635. 被引量:8
  • 3Kvinnsland S, Anker G, Dirix LY, et al. High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment[J]. Eur J Cancer, 2000, 36(8): 976-982.
  • 4Linderholm B, Andersson J, Lindh B, et al. Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor(VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment[J]. Eur J Cancer, 2004, 40(1): 33-42.
  • 5Di Giovanna NIP, Chu P, Davison TL, et al. Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates[J]. Cancer Res, 2002, 62(22): 6667- 6673.
  • 6Roychowdhury DF, Tseng A Jr, Fu KK, et al. New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and GerbB2 expression[J]. Cancer, 1996, 77(8): 1419-1426.
  • 7曾俊,周云峰,龚玲玲,张弓,王敏.血管内皮生长因子C-erbB_2,p53表达与鼻咽癌的关系[J].肿瘤防治研究,2000,27(2):86-88. 被引量:7
  • 8顾康生,吴秋良,侯景辉,汪波,管忠震.HER-2/neu基因在鼻咽癌中的表达及其临床意义[J].癌症,2001,20(8):869-872. 被引量:14
  • 9王一红,施作霖.Nm23、P53、P21、c—erbB—2基因蛋白表达在鼻咽癌淋巴结转移中的意义[J].实用肿瘤学杂志,1999,13(2):106-108. 被引量:9

二级参考文献14

  • 1吴桂梅,罗来敏,王玉东,张睿.子宫内膜腺癌组织中COX-2与VEGF的表达及相关性研究[J].中国肿瘤临床,2006,33(12):682-685. 被引量:4
  • 2孙织,王华英.环氧合酶-2在子宫内膜癌中表达及临床意义的研究进展[J].中国癌症杂志,2006,16(7):594-598. 被引量:3
  • 3黄萍,黄剑飞.C-erbB-2在子宫内膜增生性病变及内膜腺癌中的表达[J].交通医学,2006,20(4):396-397. 被引量:1
  • 4Takahashi Y, Kitadai Y, Bucana CD, et at. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer[J]. Cancer Res, 1995, 55(18): 3964-3968.
  • 5Ioachim EE, Goussia AC, Kitsiou EG, et al. Immunohistochemical expression of Retinoblastoma gene product in normal, hyperplastic and malignant endometrium. Correlation with p53 protein expression,c-erbB-2, hormone receptors'status and proliferative activity[J]. Dis Markers, 2002, 18(3): 143-152.
  • 6Ioachin E.Immunohistochemical tumour markers in cndometrial carcinoma[J]. Eur J Gynaecol Oncol, 2005, 26(4): 363-371.
  • 7Ohno S, Ohno Y, Suzuki N, et al. Multiple roles of cyclooxygenase-2 in endometrial cancer[J]. Anticancer Res, 2005.25(6A): 3679-3687.
  • 8Subbaramaiah K, Norton L, Gerald W, et al. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer:evidence for involvement of AP-1 and PEA3[J]. J Biol Chem, 2002, 277 (21): 18649-18657.
  • 9Subbaramaiah K, Howe LR, Port ER, et al. HER-2/neu status is a determinant of mammary aromatase activity in vivo:evidence tor a cyclooxygenase-2-dependent mechanism [J]. Cancer Res, 2006, 66(10): 5504-5511.
  • 10王慧,糜若然,瞿全新,陈斌其.宫颈癌中c-erbB-2蛋白表达及临床意义[J].中国肿瘤临床,1998,25(3):191-193. 被引量:7

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部